Apotex Corp Company Profile

« Back to Dashboard

What is the competitive landscape for APOTEX CORP

APOTEX CORP has thirteen approved drugs.

There are two tentative approvals on APOTEX CORP drugs.

Summary for Apotex Corp

US Patents:	0
Tradenames:	11
Ingredients:	11
NDAs:	13
Patent Litigation for Apotex Corp:	See patent lawsuits for Apotex Corp
PTAB Cases with Apotex Corp as petitioner:	See PTAB cases with Apotex Corp as petitioner

Drugs and US Patents for Apotex Corp

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Apotex Corp	NARATRIPTAN	naratriptan hydrochloride	TABLET;ORAL	091373-001	Apr 22, 2011		DISCN	No	No
Apotex Corp	MYCOPHENOLATE MOFETIL	mycophenolate mofetil	CAPSULE;ORAL	090419-001	Apr 22, 2009		DISCN	No	No
Apotex Corp	AZITHROMYCIN	azithromycin	TABLET;ORAL	065508-001	Jul 13, 2011		DISCN	No	No
Apotex Corp	CABERGOLINE	cabergoline	TABLET;ORAL	201503-001	Mar 8, 2013		DISCN	No	No
Apotex Corp	AZITHROMYCIN	azithromycin	TABLET;ORAL	065509-001	Jul 13, 2011		DISCN	No	No
Apotex Corp	VERAPAMIL HYDROCHLORIDE	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	200878-002	Apr 20, 2012		DISCN	No	No
Apotex Corp	TOLTERODINE TARTRATE	tolterodine tartrate	TABLET;ORAL	200164-002	Sep 25, 2012		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Apotex
• Apotex Corp
• Apotex Inc
• Apothecon
• Apothekernes